Similar Search Results

Increasing R&D incentives for neglected diseases : lessons from the Orphan Drug Act

Grabowski, Henry - In: International public goods and transfer of technology …, (pp. 425-456). 2005

Persistent link: https://www.econbiz.de/10003414416

Patents, innovation and access to new pharmaceuticals

Grabowski, Henry G. - In: Journal of international economic law 5 (2002) 4, pp. 849-860

Persistent link: https://www.econbiz.de/10001722195

Investments in pharmaceuticals before and after trips

Kyle, Margaret K.; McGahan, Anita M. - 2009

Persistent link: https://www.econbiz.de/10003904217

Public & private spillovers, location and the productivity of pharmaceutical research

Furman, Jeffrey L.; Kyle, Margaret K.; Cockburn, Iain; … - 2006

Persistent link: https://www.econbiz.de/10003376348

Investments in pharmaceuticals before and after TRIPS

Kyle, Margaret K.; McGahan, Anita M. - 2011

Persistent link: https://www.econbiz.de/10009156012

Investments in pharmaceuticals before and after trips

Kyle, Margaret K.; McGahan, Anita M. - In: The review of economics and statistics 94 (2012) 4, pp. 1157-1172

Persistent link: https://www.econbiz.de/10009668418

Investments in Pharmaceuticals Before and After TRIPS

Kyle, Margaret - 2009

We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the...

Persistent link: https://www.econbiz.de/10012463181

Are important innovations rewarded? : evidence from pharmaceutical markets

Kyle, Margaret K. - In: Review of industrial organization : RIO 53 (2018) 1, pp. 211-234

Persistent link: https://www.econbiz.de/10012009110

Strategic interaction among governments in the provision of a global public good

Kyle, Margaret K.; Ridley, David B.; Zhang, Su - 2017

Persistent link: https://www.econbiz.de/10011817199

Are important innovations rewarded? : evidence from pharmaceutical markets

Kyle, Margaret K. - 2017

Persistent link: https://www.econbiz.de/10011817204